Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 421, 678 (13 February 2003) | doi:10.1038/421678b
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Gastroenterologist
- South Atlanta Medical Clinic, PC (GI Group)
- Atlanta, GA, USA
Postdoctoral Fellow - Computational Genomics - Team 78 – Ref: 80464
- Wellcome Trust Sanger Institute
- Hinxton, Cambridgeshire CB10 1, UK
Cancer fears cast doubts on future of gene therapy
Erika Check
A once-promising gene-therapy treatment should be used only as a last resort, advisers to the US National Institutes of Health (NIH) said this week.Members of the NIH's Recombinant DNA Advisory Committee, meeting in Bethesda, Maryland, on 10 February, said that patients suffering from severe combined immunodeficiency disease (SCID) should be treated by gene therapy only if they fail to respond to all other treatments.
To read this story in full you will need to login or make a payment (see right).
